Division of Vascular Surgery, McGill University Health Centre, Montreal, Quebec, Canada; Division of Vascular Surgery, Jewish General Hospital, Montreal, Quebec, Canada; Division of Vascular Surgery, Tufts Medical Center, Boston, Mass; Division of Vascular and Endovascular Surgery, St. Elizabeth's Medical Center, Boston, Mass.
Division of Vascular Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
J Vasc Surg. 2018 Jun;67(6):1709-1715. doi: 10.1016/j.jvs.2017.10.073. Epub 2018 Feb 1.
The adoption of endovascular aneurysm repair (EVAR) during the past two decades has led to significantly shorter length of stay as well as lower hospital resource use. Currently, most patients are admitted to the hospital after EVAR; however, there are no standard observation periods, and timing of discharge is based on clinical judgment. The aim of this study was to confirm the safety and feasibility of performing EVAR as outpatient surgery.
We developed criteria to identify patients for potential same-day discharge (infrarenal aneurysm, low perioperative risk, to be accompanied for first 24 hours). We then implemented a prospective trial that observed patients planned for same-day discharge and compared them with a historical control group (patients who had undergone EVAR during the previous 2 years and met same-day discharge criteria). Basic demographic and operative data as well as length of stay, inpatient and perioperative complications, emergency department visits, readmissions, reinterventions, and deaths were collected. The primary outcome was the 30-day complication rate, and the study was powered to assess noninferiority.
Prospectively, we assessed 266 patients and planned 110 (41%) for outpatient EVAR (62% of historical controls met outpatient criteria). Demographic characteristics were similar between planned outpatients and historical controls. In planned outpatients, hospital stay was significantly shorter (0.7 ± 2.6 days vs 2.5 ± 6.9 days; P < .01), and 79% were discharged the same day of surgery. The 30-day follow-up was available for all study patients and 94% of control patients; there were no differences in complication (11% vs 9%), readmission (2% vs 4%), reintervention (4% vs 4%), or mortality (1% vs 1%) rates, but study patients had significantly more emergency department visits (15% vs 6%; P < .05). Unsuccessful same-day discharge was associated with longer operative times, increased blood loss, and use of general anesthesia.
In selected patients undergoing elective EVAR, same-day discharge is feasible without increasing complication rates. Health resource utilization remains a challenge in transitioning to an outpatient model.
在过去的二十年中,血管内动脉瘤修复术(EVAR)的采用导致住院时间明显缩短,医院资源的使用也有所降低。目前,大多数患者在 EVAR 后住院;然而,目前没有标准的观察期,出院时间是基于临床判断。本研究的目的是确认在门诊进行 EVAR 的安全性和可行性。
我们制定了标准,以确定潜在的当天出院患者(肾下型动脉瘤,围手术期风险低,需要在头 24 小时内有人陪同)。然后,我们实施了一项前瞻性试验,观察计划当天出院的患者,并将其与历史对照组(在过去 2 年中接受过 EVAR 且符合当天出院标准的患者)进行比较。收集了基本人口统计学和手术数据以及住院时间、住院和围手术期并发症、急诊就诊、再入院、再介入和死亡等数据。主要结局是 30 天并发症发生率,该研究具有评估非劣效性的能力。
前瞻性地,我们评估了 266 名患者,并计划为 110 名患者(41%)进行门诊 EVAR(62%的历史对照组符合门诊标准)。计划门诊患者和历史对照组的人口统计学特征相似。在计划门诊患者中,住院时间明显缩短(0.7±2.6 天比 2.5±6.9 天;P<.01),79%的患者在同一天出院。所有研究患者和 94%的对照组患者均进行了 30 天随访;并发症(11%比 9%)、再入院(2%比 4%)、再介入(4%比 4%)或死亡率(1%比 1%)无差异,但研究患者急诊就诊明显更多(15%比 6%;P<.05)。当天出院不成功与手术时间延长、失血增加和使用全身麻醉有关。
在选择性接受择期 EVAR 的患者中,当天出院是可行的,不会增加并发症发生率。向门诊模式过渡仍然是医疗资源利用的一个挑战。